The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, double-blind phase 3 study evaluating neoadjuvant platinum-based chemotherapy with perioperative pembrolizumab or placebo in resectable stage IIB or IIIA NSCLC: KEYNOTE-671.
 
Hiran C. Fernando
Honoraria - Galil Medical; Merck; Pinnacle Biologics
Consulting or Advisory Role - Merck
Speakers' Bureau - Pinnacle Biologics
 
Jing Yang
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Geri L Ferraro
Employment - Merck Sharp & Dohme; Merck Sharp & Dohme (I)
Stock and Other Ownership Interests - Merck Sharp & Dohme (I)
Research Funding - Merck Sharp & Dohme (Inst)
 
Steven M. Keller
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme